Automating Surveillance for the Analysis of Adverse Event Case Reports

被引:0
|
作者
Lionel O. Benson
Linda Marc
机构
[1] Astra Merck Inc.,Clinical Operations & Product Safety
[2] Astra Merck Inc.,Product Safety & Epidemiology
关键词
Adverse event; Surveillance; Computer assisted surveillance;
D O I
暂无
中图分类号
学科分类号
摘要
The traditional method of manually reviewing large numbers of adverse event reports is not conducive to efficiently maintaining an up-to-date safety profile of a drug or to rapidly responding to inquiries on adverse events. The development of a computerized system was undertaken to perform the preliminary scrutiny of enormous quantities of information by evaluating the unique contents of each case report and quantifying the results. This paper will focus on how a computerized surveillance system identifies, in a patient’s record, concomitant drugs and preexisting medical conditions known to be associated with the adverse event under surveillance. The automated capability is not meant to replace the function of the expert medical reviewer but to assist in rapidly drawing attention to case reports that require further skilled review. Automating surveillance can improve the quality of AE review and also allow more efficient use of limited resources.
引用
收藏
页码:825 / 832
页数:7
相关论文
共 50 条
  • [31] Automating Surveillance
    Andrejevic, Mark
    SURVEILLANCE & SOCIETY, 2019, 17 (1-2) : 7 - 13
  • [33] Spontaneous adverse event reports associated with zolpidem
    Wong, C. K.
    Marshall, N. S.
    Grunstein, R. R.
    Hibbs, D. E.
    Fois, R. A.
    Ho, S. S.
    Hanrahan, J. R.
    Saini, B.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2016, 12 (05): : E24 - E24
  • [34] Guidelines for submitting adverse event reports for publication
    Kelly, William N.
    Arellano, Felix M.
    Barnes, Joanne
    Bergman, Ulf
    Edwards, I. Ralph
    Fernandez, Alina M.
    Freedman, Stephen B.
    Goldsmith, David I.
    Huang, Kui
    Jones, Judith K.
    McLeay, Rachel
    Moore, Nicholas
    Stather, Rosie H.
    Trenque, Thierry
    Troutman, William G.
    van Puijenbroek, Eugene
    Williams, Frank
    Wise, Robert P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (05) : 581 - 587
  • [35] The quality of published adverse drug event reports
    Kelly, WN
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (12) : 1774 - 1778
  • [36] Guidelines for submitting adverse event reports for publication
    Kelly, William N.
    Arellano, Felix M.
    Barnes, Joanne
    Bergman, Ulf
    Edwards, Ralph I.
    Fernandez, Alina M.
    Freedman, Stephen B.
    Goldsmith, David I.
    Huang, Kui A.
    Jones, Judith K.
    McLeay, Rachel
    Moore, Nicholas
    Stather, Rosie H.
    Trenque, Thierry
    Troutman, William G.
    van Puijenbroek, Eugene
    Williams, Frank
    Wise, Robert P.
    DRUG SAFETY, 2007, 30 (05) : 367 - 373
  • [37] Guidelines for Submitting Adverse Event Reports for Publication
    William N. Kelly
    Felix M. Arellano
    Joanne Barnes
    Ulf Bergman
    Ralph I. Edwards
    Alina M. Fernandez
    Stephen B. Freedman
    David I. Goldsmith
    Kui A. Huang
    Judith K. Jones
    Rachel McLeay
    Nicholas Moore
    Rosie H. Stather
    Thierry Trenque
    William G. Troutman
    Eugene van Puijenbroek
    Frank Williams
    Robert P. Wise
    Drug Safety, 2007, 30 : 367 - 373
  • [38] Clinical safety of daridorexant in insomnia treatment: Analysis of FDA adverse event reports
    Wang, Qi
    Zhou, Qin
    Du, Zhiqiang
    Lu, Rongrong
    Jiang, Ying
    Zhu, Haohao
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 362 : 552 - 559
  • [39] Adverse Event Profiles of PARP Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS
    Tian, Xiaojiang
    Chen, Lin
    Gai, Di
    He, Sijie
    Jiang, Xuan
    Zhang, Ni
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [40] A Quantitative Analysis of FDA Adverse Event Reports with Oral Bisphosphonates and Clostridium difficile
    McConeghy, Kevin W.
    Soriano, Melinda M.
    Danziger, Larry H.
    PHARMACOTHERAPY, 2016, 36 (10): : 1095 - 1101